Comparative Effectiveness and Safety of Direct Oral Anticoagulants vs Warfarin Among Obese Patients With Atrial Fibrillation
Author:
Funder
Fonds de Recherche du Québec - Santé
RQRM
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference42 articles.
1. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies;Wong;JACC Clin Electrophys,2015
2. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial;Boriani;Eur Heart J,2019
3. Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)
4. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH;Martin;J Thromb Haemost,2016
5. The use of dabigatran according to body mass index: the RE-LY experience [abstract P6257];Ezekowitz;Eur Heart J,2014
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Safety and efficacy of direct oral anticoagulants in comparison to warfarin in obese patients with atrial fibrillation: A systematic review and meta‐analysis;Health Science Reports;2024-04
2. Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders;Journal of Personalized Medicine;2023-08-28
3. The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis;Cureus;2023-07-10
4. Fibrilación auricular y obesidad: dos enfermedades epidémicas con interacciones complejas;Cardiovascular and Metabolic Science;2023
5. Dilemmas Related to Direct-Acting Oral Anticoagulant Administration in Patients With Extreme Obesity;Annals of Pharmacotherapy;2022-10-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3